What is Alzheimer's?
Alzheimer's is a type of dementia that affects memory, thinking, and behavior. Symptoms eventually grow severe enough to interfere with daily tasks.
Alzheimer's is a type of dementia that affects memory, thinking, and behavior. Symptoms eventually grow severe enough to interfere with daily tasks.
Alzheimer's is not a normal part of aging. The greatest known risk factor is increasing age, and the majority of people with Alzheimer's are 65 and older. Alzheimer’s disease is considered to be younger-onset Alzheimer’s if it affects a person under 65. Younger-onset can also be referred to as early-onset Alzheimer’s. People with younger-onset Alzheimer’s can be in the early, middle or late stage of the disease.
Alzheimer's is the most common cause of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60-80% of dementia cases.
There is no cure, but treatments can ease symptoms and make life better. Currently, symptomatic treatments prescribed in the early to moderate stages of the disease involve medications such as cholinesterase inhibitors, like donepezil, and NMDA receptor antagonists, like memantine, to manage cognitive decline. Symptoms that might occur along with the primary disease include depression, anxiety, and aggression, which could be treated with medication.
Exciting advances in the study of Alzheimer's disease are seeking to slow the course of the disease, and also promote early detection. Therapies that aim to target amyloid, like Aducanumab, commercially known as Aduhelm, seek to rid the brain of amyloid plaques-a classic hallmark of Alzheimer's. Tau-targeting treatments-against tangles of proteins which cause disruption in the functioning of the brain-are under clinical trials. Immunotherapies and gene-editing technologies such as CRISPR are in studies with the aim to alter the course of the disease at a molecular level.
Besides this, interest in early diagnosis through biomarkers and advanced imaging has been on the rise; this would enable timely intervention. Other promising areas include stem cell therapies and those directed at neuroinflammation. While there is no cure yet, the rapid pace of research brings hope that more effective treatments-and even strategies for prevention-may be around the corner.